- Home
- About us
- Products
- Bioreactors and Fermentors Cell Culture Fermenter Fermentor Bioreactor
- Other Bioprocess Equipment Automatic Fermenter Bioreactor 100l Fermenter bacteria Bioreactor
- Mammalian Cell Bioreactor 200l Bioreactor Stainless Steel Bioreactor bioreactor Fermenter
- Lab Fermenter Bioreactor Industrial Stainless Steel Fermenter
- Vaccine Fermenter(GMP) Fermentation Equipment stainless Steel Bioreactor
- Mini Lab Glass Fermenter Magnetic Mixing Cell Culture Fermenter Bioreactor
- CIP Station Automatic Bioreactor Fermenter
- Faqs
- News
- Certificate
- Contact us
Suddenly! Two party lawmakers in the United States: restrict exports of American biotechnology to China!
time2025/01/16
- US lawmakers from both parties have called for restrictions on exporting biotechnology to China, highlighting the importance and sensitivity of biotechnology in international relations.
Chinese biotechnology and biopharmaceutical companies need to accelerate the research and development of core technologies, improve industrial and supply chain guarantees, and play a role in safeguarding national security, economic development, and public health!
US lawmakers demand restrictions on exporting biotechnology to China
On January 9th, Democratic and Republican lawmakers in the United States jointly called on the Biden administration to consider restricting exports of American biotechnology to China, fearing that these technologies could be weaponized.
The letter was issued by the Chairman of the House Select Committee on China, Mueller, requesting that Commerce Secretary Raymondo explore licensing restrictions on American pharmaceutical companies that have medical cooperation with the Chinese military.
Competition in biotechnology and biopharmaceuticals between China and the United States is the future focus
The lawmakers pointed out in the letter that the biotechnology competition between China and the United States not only affects the national and economic security of the United States, but may also have an impact on the future of healthcare and the security of American medical data.
This indicates that competition in the field of biotechnology has gone beyond the purely economic realm, involving broader areas such as national security and public health.
White House: Whether Harris or Trump wins, they will support biomanufacturing and synthetic biology!
Response and Measures from China and the United States
The US Department of Commerce has not yet commented on this, and the term of Commerce Secretary Raymondo is coming to an end, so it is unlikely that she will have time to implement new biotechnology restrictions.
This may mean that the implementation of relevant restrictive measures will be postponed or reassessed.
Chinese Embassy spokesperson Liu Pengyu strongly opposes these accusations, stating that they are filled with malicious speculation about China. He emphasized that he firmly opposes any country developing, possessing or using biological weapons, and pointed out that these accusations lack factual basis.
Last August, some US lawmakers called on the US Food and Drug Administration (FDA) to strengthen its scrutiny of clinical trials conducted by the US in China, pointing out the risk of intellectual property theft.
This series of actions demonstrates the sensitivity of the United States in the field of biotechnology and its distrust of China.
